|
| Press Releases |
|
 |
|
| Friday, November 15, 2019 |
|
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
| Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
| Tuesday, October 29, 2019 |
|
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
| SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Wednesday, June 12, 2019 |
|
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
| SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, November 7, 2018 |
|
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
| Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
| Monday, June 18, 2018 |
|
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
| The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
| Thursday, May 31, 2018 |
|
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
| Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, March 1, 2018 |
|
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
| Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
| Wednesday, November 1, 2017 |
|
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
| SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富途私人財富中心（Private Wealth Management）聯合中國碳中和发展集团（HK.1372) 成功舉辦零碳徒步活動
May 27, 2023 10:07 HKT/SGT
|
|
|
A Bigger InfoComm Asia 2023 Set to Inspire Digital Transformation
May 27, 2023 00:05 HKT/SGT
|
|
|
Chic Hong Kong Grand Opening at COCO Park Shenzhen
May 26, 2023 22:00: JST
|
|
|
Chic Hong Kong Grand Opening at COCO Park Shenzhen
May 26, 2023 21:00 HKT/SGT
|
|
|
Vivid Sydney 2023 Lights Up Its Greatest Festival Yet
May 26, 2023 19:45 HKT/SGT
|
|
|
Vivid Sydney 2023 Lights Up Its Greatest Festival Yet
May 26, 2023 19:45 HKT/SGT
|
|
|
Imposing island challenge awaits TOYOTA GAZOO Racing
May 26, 2023 17:35 JST
|
|
|
Results of a Collision Test Conducted on the Driver's Side of a Toyota RAIZE
May 26, 2023 15:07 JST
|
|
|
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
May 26, 2023 14:15 JST
|
|
|
6th Edition of Global CX Summit, Mumbai; Physical Conference on July 6, 2023
May 26, 2023 11:48: JST
|
|
|
Honda、ロードスポーツモデル「GB350」「GB350 S」の仕様を一部変更し発売
May 26, 2023 11:30: JST
|
|
|
磷酸鐵鋰王者再領潮流，國軒高科發佈重磅新品
May 26, 2023 11:25 HKT/SGT
|
|
|
磷酸铁锂王者再领潮流，国轩高科发布重磅新品
May 26, 2023 11:24 HKT/SGT
|
|
|
富士通、「Fujitsu Technology and Service Vision 2023」を策定
May 26, 2023 11:00: JST
|
|
|
6th Edition of Global CX Summit, Mumbai; Physical Conference on July 6, 2023
May 26, 2023 10:48 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
